SCYNEXIS
SCYX
$1.97
Share price
-3.43%
Change (1 day)
-29.14%
Change (1 year)
Categories
Market capitalization of SCYNEXIS (SCYX)
Market cap: $74.42 Million
As of May 2024 SCYNEXIS has a market cap of $74.42 Million. This makes SCYNEXIS the world's 7590th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of SCYNEXIS from 2014 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $74.42 M | -10.3% |
| 2023 | $82.97 M | 62.87% |
| 2022 | $50.94 M | -65.13% |
| 2021 | $0.14 B | -0.95% |
| 2020 | $0.14 B | 66.38% |
| 2019 | $88.64 M | 283.62% |
| 2018 | $23.1 M | -65.12% |
| 2017 | $66.25 M | -13.42% |
| 2016 | $76.53 M | -11.38% |
| 2015 | $86.35 M | 1.65% |
| 2014 | $84.95 M |
End of Day market cap according to different sources
On May 14th, 2024 the market cap of SCYNEXIS was reported to be:
$74.42 Million
$74.42 Million
$74.42 Million
$74.04 Million
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Galmed Pharmaceuticals
GLMD | $2.42 M | -96.74% | 🇮🇱 Israel |
 Catalyst Pharmaceuticals CPRX | $1.94 B | 2,516.98% | 🇺🇸 USA |
 Catalent CTLT | $10.04 B | 13,400.63% | 🇺🇸 USA |
 KemPharm KMPH | $0.20 B | 169.36% | 🇺🇸 USA |